Progress and Prospects in Parkinson's Research/Symptoms/Madopar

( To subpage for editing >> )

MADOPAR ® is widely prescribed for the treatment of Parkinson’s disease symptoms.

Active ingredients

Levodopa, an aromatic amino acid, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 197.2. It is designated chemically as (—)-L-α-amino-β-(3,4-dihydroxybenzene) propanoic acid. Its empirical formula is C₉H₁₁NO₄.

Decarboxylase benzeraside

Most common adverse reactions to MADOPAR

Allergies (rash, itch,irregular heartbeat, blood in stools)

Reduced white blood cells (infections of mouth, gums, lungs or throat)

Reduced red blood cells (fatigue, bruise easily, prone to infections)

Reduced platelets in blood (bruising, nose bleeds)

Less common adverse reactions to MADOPAR

Digestive system

Loss of appetite

Nausea

Diarrhoea

Heart and circulatory system

Dizziness

Blood

Anaemia (Palpitations, Pale skin, Fatigue, Heart flutters, Shortness of breath).

Mental Problems

Excitement, Anxiety, Agitation, Agressin, Depression, Disorientation.

Hallucinations, Out of touch with reality.

Narcolepsy, Insomnia.

Excessive urge to gamble.

Excessive sex drive.

Miscellaneous

Dyskinesia.

Loss of taste, Taste abnormalities.

Redness of face or neck.

Abnormal sweating.

Further reading

Search the scientific literature (Madopar)
Literature search: Use the following links to query the PubMed, PubMed Central and Google Scholar databases using the Search terms:- Parkinson's_Disease Madopar. This will list the latest papers on this topic. You are invited to update this page to reflect such recent results, pointing out their significance. Pubmed (abstracts) Pubmed_Central (Full_Text) Google_Scholar